Santa Ana Bio

Alameda, CA · Founded 2020 · Privately Held (backing)

Operator of a biotechnology company intended to develop precision immunology for autoimmune diseases. Santa Ana Bio is based in Alameda, CA and was founded in 2020. Its last known valuation is $270 million. It has raised $203 million across 3 recorded rounds; the latest was a $20 million early-stage round in May 2024.

Last price · $/share
—
Implied valuation
$270.0M
Total raised
$203.0M
Last round
Early Stage VC
May 2024
How much has Santa Ana Bio raised?
$203.0Macross 3 recorded rounds · May 2021 – May 2024

Most recently, Santa Ana Bio raised $20.0M in its Early Stage VC (May 2024).

Free account
More of Santa Ana Bio with a free account
  • ·Watch Santa Ana Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Santa Ana Bio round by round

3 rounds
May 2024Early Stage VC$20.0MSEC filing▮
10 investors participated
Feb 2023Early Stage VC$35.3MSEC filing▮
5 investors participated
May 2021Early Stage VC$8.0MSEC filing▮
1 investors participated

How much has Santa Ana Bio raised?

Santa Ana Bio has raised $203 million in total; 3 of its rounds are on record, from 2021 on. The largest on record was an $8 million early-stage round in May 2021; the most recent was a $20 million early-stage round in May 2024.

Santa Ana Bio has filed 3 Form Ds with the SEC since 2021, most recently in Jun 2024 ($20 million sold to 10 investors).

Santa Ana Bio investors

6 investors are on record for Santa Ana Bio, including Andreessen Horowitz, GV, RTW Investments and Versant Ventures. The early-stage round in May 2024 drew 10 investors.

For fundraisers
Raising for a company like Santa Ana Bio?

6 investors have backed Santa Ana Bio.

See all 6 investors →

Frequently asked about Santa Ana Bio

How much has Santa Ana Bio raised?
Santa Ana Bio has raised $203.0M in total across 3 recorded funding rounds.
When was Santa Ana Bio's last funding round?
Santa Ana Bio's most recent recorded round was Early Stage VC in May 2024, raising $20.0M.